The Anti-Counterfeiting Trade Agreement (ACTA) has been characterised by a flawed process of negotiations based on a flawed rationale, which has resulted in a flawed agreement, argue Sophie Bloemen and Tessel Mellema from Health Action International Europe. One of the concerns now is that – designed to be a global norm-setting instrument – ACTA could deter generic competition of medicines around the world. […]
http://www.euractiv.com/health/acta-access-medicines-flawed-process-rationale-agreement-analysis-511408